Jentashapir Journal of Health Research

Published by: Neoscriber Demo Publisher

Effect of Ellagic Acid on Animal Behavior in Elevated Plus Maze and Open Field Tests

Yaghoob Farbood 1 , * , Seyyed Mohammad Taghi Mansouri 2 , Seyyed Mostafa Ahmadian 1 , Seyyad Ali Mard 1 and Alireza Sarkaki 1
Authors Information
1 Department of Physiology, Physiology Research Center, Medical School, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Department of Pharmacology, Physiology Research Center, Medical School, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jentashapir Journal of Health Research: December 2015, 6 (6); e29311
  • Published Online: December 14, 2015
  • Article Type: Research Article
  • Received: April 17, 2015
  • Revised: June 22, 2015
  • Accepted: July 13, 2015
  • DOI: 10.17795/jjhr-29311

To Cite: Farbood Y, Mansouri S M T, Ahmadian S M, Mard S A, Sarkaki A. et al. Effect of Ellagic Acid on Animal Behavior in Elevated Plus Maze and Open Field Tests, Jundishapur J Helath Res. 2015 ;6(6):e29311. doi: 10.17795/jjhr-29311.

Abstract
Copyright: Copyright © 0, Jentashapir Journal of Health Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Pollack MH. New advances in the management of anxiety disorders. Psychopharmacol Bull. 2002; 36(4): 79-94[PubMed]
  • 2. Shorter E, Tyrer P. Separation of anxiety and depressive disorders: blind alley in psychopharmacology and classification of disease. BMJ. 2003; 327(7407): 158-60[DOI][PubMed]
  • 3. Kunovac JL, Stahl SM. Future directions in anxiolytic pharmacotherapy. Psychiatr Clin North Am. 1995; 18(4): 895-909[PubMed]
  • 4. Girish C, Raj V, Arya J, Balakrishnan S. Involvement of the GABAergic system in the anxiolytic-like effect of the flavonoid ellagic acid in mice. Eur J Pharmacol. 2013; 710(1-3): 49-58[DOI][PubMed]
  • 5. Medina JH, Peña C, Levi de Stein M, Wolfman C, Paladini AC. Benzodiazepine-like molecules, as well as other ligands for the brain benzodiazepine receptors, are relatively common constituents of plants. Biochem Biophys Res Commun. 1989; 165(2): 547-53[DOI]
  • 6. Priyadarsini KI, Khopde SM, Kumar SS, Mohan H. Free radical studies of ellagic acid, a natural phenolic antioxidant. J Agric Food Chem. 2002; 50(7): 2200-6[PubMed]
  • 7. Kaur S, Grover IS, Kumar S. Antimutagenic potential of ellagic acid isolated from Terminalia arjuna. Indian J Exp Biol. 1997; 35(5): 478-82[PubMed]
  • 8. Makena PS, Chung KT. Effects of various plant polyphenols on bladder carcinogen benzidine-induced mutagenicity. Food Chem Toxicol. 2007; 45(10): 1899-909[DOI][PubMed]
  • 9. Cozzi R, Ricordy R, Bartolini F, Ramadori L, Perticone P, De Salvia R. Taurine and ellagic acid: two differently-acting natural antioxidants. Environ Mol Mutagen. 1995; 26(3): 248-54[PubMed]
  • 10. Rogerio AP, Fontanari C, Melo MC, Ambrosio SR, de Souza GE, Pereira PS, et al. Anti-inflammatory, analgesic and anti-oedematous effects of Lafoensia pacari extract and ellagic acid. J Pharm Pharmacol. 2006; 58(9): 1265-73[DOI][PubMed]
  • 11. Papoutsi Z, Kassi E, Chinou I, Halabalaki M, Skaltsounis LA, Moutsatsou P. Walnut extract (Juglans regia L.) and its component ellagic acid exhibit anti-inflammatory activity in human aorta endothelial cells and osteoblastic activity in the cell line KS483. Br J Nutr. 2008; 99(4): 715-22[DOI][PubMed]
  • 12. Kim S, Gaber MW, Zawaski JA, Zhang F, Richardson M, Zhang XA, et al. The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acid composite biomaterial. Biomaterials. 2009; 30(27): 4743-51[DOI]
  • 13. Yang CS, Tzou BC, Liu YP, Tsai MJ, Shyue SK, Tzeng SF. Inhibition of cadmium-induced oxidative injury in rat primary astrocytes by the addition of antioxidants and the reduction of intracellular calcium. J Cell Biochem. 2008; 103(3): 825-34[DOI]
  • 14. Bueno CH, Zangrossi Jr H, Viana MB. The inactivation of the basolateral nucleus of the rat amygdala has an anxiolytic effect in the elevated T-maze and light/dark transition tests. Brazil J Med Biol Res. 2005; 38(11): 1697-701[DOI]
  • 15. Carlo CN, Stefanacci L, Semendeferi K, Stevens CF. Comparative analyses of the neuron numbers and volumes of the amygdaloid complex in old and new world primates. J Comp Neurol. 2010; 518(8): 1176-98[DOI][PubMed]
  • 16. Pellow S, Chopin P, File SE, Briley M. Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods. 1985; 14(3): 149-67[DOI]
  • 17. Kõks S, Beljajev S, Koovit I, Abramov U, Bourin M, Vasar E. 8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze. Psychopharmacology. 2000; 153(3): 365-72[DOI]
  • 18. Archer J. Tests for emotionality in rats and mice: A review. Anim Behav. 1973; 21(2): 205-35[DOI]
  • 19. Galdino PM, Nascimento MV, Sampaio BL, Ferreira RN, Paula JR, Costa EA. Antidepressant-like effect of Lafoensia pacari A. St.-Hil. ethanolic extract and fractions in mice. J Ethnopharmacol. 2009; 124(3): 581-5[DOI][PubMed]
  • 20. Wang Q, Han Y, Xue H. Ligands of the GABAA Receptor Benzodiazepine Binding Site. CNS Drug Rev. 2006; 5(2): 125-44[DOI]
  • 21. Marder M, Paladini AC. GABA(A)-receptor ligands of flavonoid structure. Curr Top Med Chem. 2002; 2(8): 853-67[PubMed]
  • 22. Fernandez SP, Wasowski C, Loscalzo LM, Granger RE, Johnston GA, Paladini AC, et al. Central nervous system depressant action of flavonoid glycosides. Eur J Pharmacol. 2006; 539(3): 168-76[DOI][PubMed]
  • 23. Hall BJ, Chebib M, Hanrahan JR, Johnston GA. 6-Methylflavanone, a more efficacious positive allosteric modulator of gamma-aminobutyric acid (GABA) action at human recombinant alpha2beta2gamma2L than at alpha1beta2gamma2L and alpha1beta2 GABA(A) receptors expressed in Xenopus oocytes. Eur J Pharmacol. 2005; 512(2-3): 97-104[DOI][PubMed]
  • 24. Girish C, Pradhan SC. Drug development for liver diseases: focus on picroliv, ellagic acid and curcumin. Fundam Clin Pharmacol. 2008; 22(6): 623-32[DOI][PubMed]
  • 25. Girish C, Raj V, Arya J, Balakrishnan S. Evidence for the involvement of the monoaminergic system, but not the opioid system in the antidepressant-like activity of ellagic acid in mice. Eur J Pharmacol. 2012; 682(1-3): 118-25[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader